Abstracts

DIFFERENTIATION ENHANCES REACTIVATION OF HIV-1 IN CD4+ T CELLS AFTER LONG-TERM ART

Background: Accurately quantifying the frequency of HIV-1 infected CD4+ T cells in people living with HIV (PLWH) on anti-retroviral therapy (ART) remains a significant barrier to evaluation of cure strategies. Molecular measurements cannot discriminate replication fitness of intact provirus, while the Quantitative Viral Outgrowth Assay (QVOA) has been shown to underestimate the viral reservoir frequency.…

NONHUMAN PRIMATE MODEL OF LONG COVID: IMMUNE INSIGHTS OF GLYCOMETABOLIC DYSFUNCTIONS

Background: A major consequence of COVID-19 is long-term metabolic complications (metabolic PASC or Long COVID) following acute disease resolution leading to hyperglycemia, increased risk of diabetes or defects in glucose metabolism. However, the mechanisms underlying the links between COVID-19 and glycometabolic disruptions remain unclear. Methods: 15 African green monkeys (AGM; Chlorocebus aethiops) were infected with…

MATERNAL BROADLY NEUTRALIZING ANTIBODY ACTIVITY AND PERINATAL TRANSMISSION OF HIV-1

Background: Over 150,000 children are infected with HIV-1 every year. Despite increased availability and access to antiretroviral therapy (ART), up to 5% of women with HIV still transmit the virus to their infants. While development of broadly neutralizing antibodies (bNAbs) through vaccination and therapeutic interventions are intended to prevent mother-to-child-transmission of HIV-1, recent evidence suggests…

INTERACTIONS BETWEEN GUT MICROBIOTA SIGNATURES AND CNS STATUS IN A HIV CURE STRATEGY

Background: The microbiome-gut-brain axis interplay is a major player in regulating the CNS status. In a substudy from the BCN02 trial, pro-inflammatory microbial signatures were identified as potential predictors of immune-mediated HIV-1 control in the absence of ART. Assessments from a BCN02 substudy investigating the CNS safety of using the histone deacetylase inhibitor romidepsin (RMD)…

EXERCISE CAPACITY IS REDUCED IN HIV INDEPENDENT OF SARS-CoV-2 INFECTION

Background: Reduced exercise capacity occurs as a post-acute sequela of COVID-19 (“PASC” or “Long COVID”). Cardiopulmonary exercise testing (CPET) is the gold standard for measuring exercise capacity and identifying reasons for exercise limitations. Only one prior study used CPET to examine exercise limitations among people living with HIV (PLWH). Extending our prior findings in PASC,…